Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents

Ruifeng Wang(Shenyang Pharmaceutical University), Maosheng Cheng(Shenyang Pharmaceutical University), Jing Guo(Harbin Medical University), Xiangxin Zhao(Shenyang Pharmaceutical University), Bowen Yang(Hunan Institute of Engineering), Chenzhou Hao(Shenyang Pharmaceutical University), Yixuan Chen(Shenyang Pharmaceutical University), Dongmei Zhao(Shenyang Pharmaceutical University), Tianxiao Wu(Shenyang Pharmaceutical University), Sijia Yu(Shenyang Pharmaceutical University)
European Journal of Medicinal Chemistry
September 18, 2019
10.1016/j.ejmech.2019.111716
Cited by 40

Related Papers

Reactive Oxygen Species (ROS)-Based Nanomedicine
|Chemical Reviews|2019|2.4k
Nanocatalytic Medicine
|Advanced Materials|2019|605
Exosome Biochemistry and Advanced Nanotechnology for Next‐Generation Theranostic Platforms
|Advanced Materials|2018|420
Tailored Amphiphilic Molecular Mitigators for Stable Perovskite Solar Cells with 23.5% Efficiency
|Advanced Materials|2020|411
2D‐Black‐Phosphorus‐Reinforced 3D‐Printed Scaffolds:A Stepwise Countermeasure for Osteosarcoma
|Advanced Materials|2018|392